February 15, 2022
Marinomed receives € 6 M with final tranche of financing agreement with EIB to invest in proprietary R&D pipeline
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, today…